NPY5 receptor antagonists and methods for using same
US6245817A · kind A · utility
22Cited by
9References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 20, 1999 |
| Grant date | Jun 12, 2001 |
| Priority date | — |
| Expiry date | Apr 20, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
.alpha.-alkoxy and .alpha.-thioalkoxyamide compositions and methods of administering the compositions to mammals to treat disorders such as obesity that are mediated by NPY and especially those mediated by NPY via the Y5 receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.